Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Recommendations for the Laboratory-Based Detection of *Chlamydia trachomatis* and *Neisseria gonorrhoeae* — 2014








Appendix						Print
																Related Pages
										Key Questions Reviewed by the Work Group and Member(s) Responsible for Literature Summary
Performance Characteristics
Does the sensitivity and specificity of available tests for *C. trachomatis* and *N. gonorrhoeae* vary with respect to anatomic site from which the specimen was collected and/or specimen type?
Joan Chow, DrPH, California Department of Public Health, Richmond, California
Katherine Whitaker, PhD, Food and Drug Administration, Rockville, Maryland
What recommendations should be made for the detection of *C. trachomatis* and *N. gonorrhoeae* infections of the genital tract, rectum, and throat?
Gary Budnick, MHS, Connecticut Department of Public Health Laboratory, Hartford, Connecticut
Steven Shapiro, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Rick Steece, PhD, Infertility Prevention Project Laboratory Consultant, Pierre, South Dakota
What test recommendations should be made for the diagnosis of suspected LGV infections (inguinal and rectal presentations)?
Lisa Steele, PhD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDCScreening Applications
What specimen types are optimal for of *C. trachomatis* and *N. gonorrhoeae* screening purposes?
Charlotte Gaydos, DrPH, Johns Hopkins University, Baltimore, Maryland
Sarah Guerry, MD, Los Angeles County Department of Health Services, Los Angeles, California
Barbara Van Der Pol, PhD, Indiana University School of Public Health, Bloomington, Indiana
What parameters should be considered when selecting a *C. trachomatis* and *N. gonorrhoeae* test for screening purposes?
George Dizikes, PhD, Illinois Department of Public Health, Chicago, Illinois
Robert E Johnson, MD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Scott Zimmerman, DrPH, Erie County Public Health Laboratory, Buffalo, New YorkEconomic Considerations
What economic considerations might influence laboratory testing?
Thomas Gift, PhD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDCLaboratory Confirmation
What approaches, if any, can be used to derive a definitive laboratory confirmation of *C. trachomatis* and *N. gonorrhoeae*?
Yetunde Fakile, PhD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Dennis Ferrero, MPH, Department of Biological Sciences, University of the Pacific, Stockton, California
Rick Steece, PhD, Infertility Prevention Project Laboratory Consultant, Pierre, South Dakota
Barbara Van Der Pol, PhD, Indiana University School of Public Health, Bloomington, IndianaWork Group MembersAs of January 2009
**Chair:** John R. Papp, PhD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, Georgia.
**Presenters:** Gary Budnick, MHS, Connecticut Department of Public Health Laboratory, Hartford, Connecticut; Joan Chow, DrPH, California Department of Public Health, Richmond, California; George Dizikes, PhD, Illinois Department of Public Health, Chicago, Illinois; Dennis Ferrero, MPH, Department of Biological Sciences, University of the Pacific, Stockton, California; Charlotte Gaydos, DrPH, Johns Hopkins University, Baltimore, Maryland; Sarah Guerry, MD, Los Angeles County Department of Health Services, Los Angeles, California; Rick Steece, PhD, Infertility Prevention Project Laboratory Consultant, Pierre, South Dakota; Barbara Van Der Pol, PhD, Indiana University School of Public Health, Bloomington, Indiana; Katherine Whitaker, PhD, Food and Drug Administration, Rockville, Maryland; Scott Zimmerman, DrPH, Erie County Public Health Laboratory, Buffalo, New York; Yetunde Fakile, PhD, Thomas Gift, PhD, Robert E Johnson, MD, Steven Shapiro, Lisa Steele, PhD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, Georgia;
**Consultants:** Stefanie Akselrod, MS, Food and Drug Administration, Rockville, Maryland; James Beebe, PhD, San Luis Obispo County Health Agency, San Luis Obispo, California; Julius Schachter, PhD, University of California, San Francisco, California; Shari Shea, MPH, Association of Public Health Laboratories, Silver Spring, Maryland; Melissa Singer, MPH, Centers for Medicare and Medicaid Services, Baltimore, Maryland; Dean Willis, DrPH, Florida Department of Health (Retired), Jacksonville, Florida; Kimberly Workowski, MD, Lisa Steele, PhD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC and Emory University, Atlanta, Georgia; Kelly Wroblewski, MPH, Association of Public Health Laboratories, Silver Spring, Maryland.
							
					
							Last Reviewed:  March 31, 2017						Source: 	Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRecommendations for the Laboratory-Based Detection of *C. trachomatis* and *N. gonorrhoeae* — 2014
Introduction
Methods
Recommendations
Recommendations Continued
Conclusion
Appendix


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue